Outsourced vs In-House Medical Billing

When practice owners compare outsourced billing to in-house, they often compare a vendor's quoted percentage (say, 6%) against the salary line for their billing staff (say, two full-time billers at $52,000 each, or roughly 4-5% of collections for a $2M practice). The vendor looks more expensive. The math is wrong.

Fully loaded in-house billing cost is not just salary. It includes: employer-paid benefits and payroll taxes — BLS Employer Costs for Employee Compensation put benefits at 30.1% of total compensation for private industry in the March 2026 reference period (read 17 September 2026; BLS republishes this release quarterly at that same URL, so the live share moves by a tenth of a point), which is the figure most often misapplied: 30.1% of total compensation is a load of roughly 43% on top of salary, not 30%, so a $52,000 salary carries about $22,400 in benefits and taxes rather than $15,600, practice management and clearinghouse software (published per-provider list prices run from roughly $45 to roughly $200 a month, with clearinghouse per-claim or per-month fees on top), ongoing coding-certification renewal and CEUs for each certified biller, turnover replacement — no free source publishes an annual turnover rate for medical billers specifically, so budget the event rather than a rate: a vacancy, a recruiting cycle and a productivity ramp on the new hire, all of which fall on the practice, management oversight (the practice manager's billing-supervision time, often 20-30% of their week), denial-rate variance during transitions, and the opportunity cost of A/R sitting longer when a biller leaves mid-quarter.

Add those line items together and fully-loaded in-house cost-to-collect commonly lands at 6-10% of net collections, with smaller practices skewing toward the upper end because fixed software and training costs amortize over fewer claims. That range is the one in general circulation rather than a surveyed figure — see the note in the introduction — so compute your own from the line items above before you use it to decide anything. A vendor charging 6% and absorbing all of those line items is not necessarily more expensive. They may be more expensive on paper while being less expensive in actual dollars-out-the-door per dollar-collected. The rigorous comparison is total cost of collection, not headline rate.

No free, public source publishes denial-rate quartiles for physician practices. What is published is guidance: the AAFP states that a 5% to 10% denial rate is the industry average and that keeping the denial rate below 5% is more desirable (read 17 September 2026). The quartile bands in general circulation are widely relayed as an HFMA benchmark, but HFMA's MAP Keys publish metric definitions rather than target values, so this page does not use them. The single biggest factor separating a practice at the low end of that range from one at the high end is volume of repetition: a biller working 12,000 claims per year in a single specialty learns the payer-edit patterns faster than one working 3,000 claims across four specialties.

This is structural. A specialty-trained outsourced team that processes high volume across many practices in the same specialty sees more rare denial reasons more often, builds more accurate scrubber rules, and updates payer-rule libraries faster. An internal biller at a small practice sees denial reasons in trickle order and learns slower. That is a structural argument about repetition, not a measured gap. We have not found a published study comparing denial rates between outsourced and in-house billing at comparable practice size, and this page does not quote one.

Net collections (the percent of allowed amount actually collected) follows a similar pattern. The AAFP states that the adjusted collection rate "should be 95%, at minimum" and that the average runs 95% to 99% — practice-management guidance published without a sample or denominator, not a measured benchmark, and the figure widely relayed as an MGMA or HFMA top-quartile number traces to a secondary article rather than to published data. Whether an outsourced team collects more than an in-house one is not something we can support with a published figure, and this page does not assert a percentage-point gain. The structural argument is narrower and checkable: when one person is triaging current-quarter claims, aged-A/R follow-up is the work that gets deferred, and a vendor that staffs A/R as its own lane is funded to do it. Do the arithmetic before assuming a gain covers the fee. On a practice collecting $2 million a year, a 6% vendor fee is $120,000 gross. A two-point improvement in collections on that base is $40,000 and a four-point improvement is $80,000 — so on those numbers the improvement does not pay for the fee; it offsets part of it. The comparison that decides the question is total cost against total cost, with the fully loaded in-house figure on one side and the vendor fee plus the retained internal workload on the other, both stated with their assumptions.

Operational risk is the underweighted variable in most practice owners' comparisons. Internal billing teams introduce three structural risks the outsourced model absorbs: turnover, coverage, and accountability concentration.

Turnover risk: no free source publishes an annual turnover rate for medical billers specifically, so the honest form of this risk is structural rather than numerical. A two-person internal team has two points of failure and no bench, and a departure mid-quarter stops nothing on the day it happens — claim submission continues while follow-up quietly does not, which is why it surfaces weeks later in aged A/R rather than immediately. A vendor carries the recruiting and ramp cost on its own payroll instead of yours. That is a difference in who bears the cost, not a promise that a staffing change is invisible.

Coverage risk: if your sole biller is on PTO, has an FMLA event, or calls in sick, claims do not go out and denials do not get worked. A vendor model has overlapping team coverage; a solo internal biller has none. For a practice that needs continuous claim submission to maintain cash flow, the lack of bench is a hidden but serious risk.

Accountability concentration: when billing is internal and underperforming, the practice owner is also the person who has to manage, develop, and (sometimes) fire the underperformer. With a vendor, underperformance is contractually addressable: SLAs on first-pass acceptance rate, days-in-A/R, and net collections give you clean termination triggers. The relationship is professional, not personal. For practice owners who dislike personnel management, this is materially valuable — a fact rarely surfaced in cost-only comparisons.

Specialty mix is the most underrated factor in the outsourcing decision. A few specialties carry disproportionately complex billing rules — and that complexity tilts the math toward outsourced specialty-trained teams.

Mental health and behavioral health billing involves payer-specific authorization rules for psychotherapy CPT 90837 vs 90834, intensive-outpatient and partial-hospitalization billing under HCPCS H-codes, and 96-hour and weekly authorization renewals that vary by payer. A general internal biller often misses one of these and triggers a denial cascade.

Cardiology has high-RVU procedures (catheterization, EP studies, device implants) where a coding error is measured against the full allowed amount of the procedure rather than against a visit-level fee. Specialty-trained cardiology billers know the global-period rules, the modifier-25/-26/-TC patterns, and the device-implant tracking forms cold; generalists do not.

Oncology and infusion billing requires waste-units tracking under JW modifier, drug-NDC reporting, and 340B compliance — all of which are audit hot spots. The cost of getting these wrong is not just denials; it is potential payer recoupment audits and OIG exposure.

Physical therapy and orthopedic surgery have plan-of-care recertification timing, the 8-minute rule for time-based codes, and global-period bundling rules that drive denial patterns specific to those specialties. What these specialties share is that their expensive mistakes sit in rules a generalist biller meets rarely. That is an argument about who has seen the rule before, not a measured economic gap, and this page does not quote one. For a solo internist or family-medicine practice with high-volume but lower-complexity billing the in-house math is closer, for exactly the same reason.

Both models carry hidden costs that rarely make it onto the comparison spreadsheet. On the in-house side, the most-missed costs are: management time (the practice manager's hours spent supervising billers, reviewing aged A/R reports, and handling payroll-related issues for billing staff, often $25,000-$45,000 of equivalent comp annually), audit-prep cost (when a payer requests records or a OIG-style audit hits, internal teams scramble while vendors usually have a pre-built audit workflow), and PM-software upgrade cost (every 3-5 years your PM platform needs an update or migration; the project cost is usually $15,000-$60,000 for small practices and is borne by the practice rather than the vendor).

On the outsourced side, the most-missed costs are: implementation/onboarding fees (some vendors charge $2,000-$10,000 to set up the relationship), early-termination penalties (12-36 month auto-renew clauses that can lock you in), per-claim minimum fees that punish you on slow months, and the political/transition cost of the in-house biller departure (severance, legal review, knowledge handoff).

A defensible vendor selection negotiates these out of the contract. A defensible in-house decision budgets management time and software upgrade reserves explicitly. The point is not that one model is hidden-cost-free — neither is. The point is that an apples-to-apples comparison has to surface both.

Many practices that have run in-house billing for years are reluctant to outsource everything at once. The hybrid model lets a practice outsource specific functions while keeping core billing in-house:

Outsource credentialing only. Provider credentialing and re-credentialing is episodic, requires payer-specific expertise, and pulls in-house staff away from claims work for weeks at a time. Outsourcing credentialing alone costs $250-$600 per provider per payer and frees in-house capacity for higher-value work.

Outsource denial management and appeals. Appeals are the most under-resourced function in most in-house operations. Outsourcing just the appeal queue puts a funded owner on work that otherwise gets deferred. Whether it pays for itself depends on how much of your denied dollar volume is actually recoverable, which is a number from your own remittances rather than one we can quote.

Outsource A/R follow-up over 90 days. Some practices keep front-end billing in-house but hand aged A/R (over 90 days) to a recovery vendor on contingency (15-25% of recovered amount). The contingency structure means the vendor is paid out of what it recovers, so the cost tracks the result rather than running ahead of it.

Outsource patient statements and patient collections. The labor of statement printing, mailing, and patient phone follow-up is high relative to the dollars at stake. Many practices outsource just this layer for $3-$6 per statement plus contingency on patient collections.

The hybrid model is a low-risk way to test outsourcing on a single function before committing to a full transition.

The biggest fear in switching from in-house to outsourced (or vendor to vendor) is revenue disruption during the handoff. A well-managed transition takes 60-90 days and protects revenue at each phase.

Weeks 1-2: Discovery and access setup. New vendor inventories your payer mix, fee schedule, software environment, and current performance baseline. Access to PM, EHR, clearinghouse, and payer portals is provisioned.

Weeks 3-4: Process documentation. Current in-house workflows are documented and translated into the vendor's playbooks. Pending charges, denied claims, and aged A/R are inventoried.

Weeks 5-6: Parallel run. Vendor begins working new charges live while in-house team continues finishing older claims. KPIs are compared side-by-side. This is the critical period — both teams are working, and any handoff gaps surface here.

Weeks 7-10: Phased cutover. Vendor takes over 100% of new claims. In-house team finishes residual A/R. Old claims that fail to collect within timely-filing windows are written off or appealed.

Weeks 11-12: Stabilization and tuning. First full month of vendor-only billing produces the new baseline. Discrepancies vs forecast are reviewed and corrected.

The transition risk is real but manageable, and the parallel run is the control that manages it: while both teams are live, a handoff gap shows up in the side-by-side KPIs instead of in next quarter’s A/R. We do not publish a figure for how far days-in-A/R moves during a switch — it depends on your payer mix, your backlog and how clean the handoff data is — and you should be skeptical of any billing company that quotes one before it has seen your A/R. Ask instead how long the parallel run is and what gets compared during it.

In the first 30 days after switching to MedPrecision we complete a billing audit, run your claims workflow in parallel with the outgoing team rather than cutting over in one step, begin working your aged A/R backlog, and put front-end eligibility and authorization checks in place before charges are entered. Those are commitments about what we do and on what schedule.

We do not publish a figure for what changes afterwards. We have no case studies and no published client results, so a clean-claim or denial improvement quoted before we have seen your data would be a number we invented. What you get instead is the baseline measured during the parallel run, and the same KPIs reported against it every month, so the comparison is yours to make rather than ours to assert.

After working through the cost, performance, risk, and specialty dimensions, the decision usually resolves cleanly along three axes: practice size, specialty complexity, and team stability.

Outsource if any of the following are true: practice size is under 10 providers; specialty is anything other than primary-care/family-medicine (mental health, ortho, cardiology, oncology, PT, gastroenterology, urology, dermatology, etc.); your billing team has had 1+ turnover events in the last 24 months; your days-in-A/R is over 45 days or denial rate is above 8%; your practice is growing more than 15% per year and you cannot reliably hire-ahead-of-volume; or you are launching a new practice and need to begin claim submission within 30 days.

Keep in-house if all of the following are true: practice size is 10+ providers; specialty is primary-care or single-specialty with a tenured biller (3+ years); your PM software is modern (Athena, eClinicalWorks, AdvancedMD, Tebra/Kareo, or NextGen on a current version); you have invested in CPC/CPB training and the biller maintains certification; and your denial rate is already under 6% with stable days-in-A/R under 35.

The edge case worth flagging: hospital-employed group practices and hospital outpatient departments operate under different rules (UB-04 facility billing vs CMS-1500 professional billing) and the in-house economics shift because the parent hospital's RCM department absorbs costs. For independent practices, the framework above is the right starting point.